shadow_tr

News & Events

Shortage of Human Islet Cells Will Slow Diabetes Research

Franck Mauvais-Jarvis, M.D., Ph.D., Director of the Tulane Diabetes Research Program at Tulane University Health Sciences Center collaborated on a white paper published in Diabetes addressing this shortage.

Rohit Kulkarni, M.D., Ph.D., Senior Investigator in the Section on Islet Cell and Regenerative Biology at Joslin Diabetes Center and Associate Professor at Harvard Medical School, coauthored a paper that was published today in Diabetes, which voiced concerns about the increasing difficulty of access to high quality islet cells for diabetes research. Andrew Stewart, M.D., Director of the Diabetes, Obesity and Metabolism Institute at of Mount Sinai Hospital in New York, served as the other lead author.
Full story

Tissue-selective estrogen complexes with bazedoxifene prevent metabolic dysfunction in female mice

Proposed mechanisms of estrogen

Dr. Mauvais-Jarvis’ group publishes a study on the antidiabetic effects of a new FDA-approved menopausal treatment in preclinical models.
Full story

Mauvais-Jarvis and Collaborators Obtain State Wide Grant to Prevent Diabetes and Obesity in Louisiana Women

The Louisiana Clinical and Translational Science Center, a federally funded statewide research initiative, announced three multi-institutional grants on Wednesday.“These projects are aimed at diseases prevalent in our communities,” said Dr. William T. Cefalu, principal investigator of the LA CaTS Center grant...“Our research teams will work to develop new approaches to prevent or treat these diseases.”
Full story

Louisiana’s First Clinical Data Research Network to be Developed Through PCORI Funding

The Louisiana Clinical Data Research Network (LACDRN) was recently approved for a funding award by the Patient-Centered Outcomes Research Institute (PCORI) to develop and expand a health data network that will be part of PCORnet: the National Patient-Centered National Clinical Research Network.
Full story

Mesoblast Reports Positive Type 2 Diabetes Trial Results

The clinical trial Protocol #MSB-DM003 – “A Randomized, Placebo-Controlled, Dose-Escalation Study to Assess the Safety and Tolerability of a Single Intravenous Infusion of Allogeneic Mesenchymal Precursor Cells (MPCs) in Patients with Type 2 Diabetes Sub-optimally Controlled on Metformin”, currently being conducted at Tulane by Dr. Vivian A. Fonseca, is reporting "an improvement in glycemic control as evidenced by reduction in hemoglobin A1c (HbA1c)."
Full story

 news-row-spacer

1430 Tulane Ave, New Orleans, LA 70112 504-988-5263 medsch@tulane.edu